X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3528) 3528
Book Review (498) 498
Publication (288) 288
Book Chapter (20) 20
Conference Proceeding (9) 9
Book / eBook (3) 3
Dissertation (2) 2
Magazine Article (1) 1
Reference (1) 1
Streaming Video (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (3206) 3206
humans (2452) 2452
animals (1507) 1507
dermatology (1226) 1226
melanocytes (1139) 1139
cell biology (881) 881
male (871) 871
mice (823) 823
female (801) 801
melanoma (791) 791
melanocytes - metabolism (637) 637
skin (621) 621
biochemistry (541) 541
expression (531) 531
molecular biology (518) 518
adult (508) 508
melanocytes - immunology (487) 487
cells, cultured (471) 471
multidisciplinary sciences (445) 445
melanocytes - cytology (440) 440
melanoma - pathology (440) 440
immunology (430) 430
melanocyte-stimulating hormone (413) 413
melanocytes - pathology (413) 413
middle aged (411) 411
vitiligo (361) 361
pigmentation (355) 355
proteins (353) 353
cells (342) 342
oncology (341) 341
immunohistochemistry (335) 335
melanoma - immunology (329) 329
gene expression (317) 317
cancer (308) 308
research article (300) 300
medicine (290) 290
analysis (289) 289
melanoma - metabolism (285) 285
mutation (282) 282
skin neoplasms - pathology (274) 274
vitiligo - immunology (271) 271
cell line, tumor (269) 269
research (262) 262
melanin (255) 255
science (254) 254
mice, inbred c57bl (251) 251
aged (238) 238
biochemistry & molecular biology (235) 235
malignant-melanoma (235) 235
tyrosinase (234) 234
human melanocytes (232) 232
melanocytes - drug effects (232) 232
apoptosis (228) 228
signal transduction (227) 227
melanoma - genetics (226) 226
tumors (219) 219
article (217) 217
keratinocytes (217) 217
melanocyte (210) 210
pathology (210) 210
biology (202) 202
melanocytes - physiology (199) 199
in-vitro (193) 193
adolescent (192) 192
tumor cells, cultured (191) 191
activation (190) 190
skin cancer (190) 190
melanogenesis (187) 187
differentiation (185) 185
genetic aspects (185) 185
rats (185) 185
genes (183) 183
inflammation (182) 182
gene (174) 174
cell line (171) 171
molecular sequence data (166) 166
physiological aspects (166) 166
abridged index medicus (164) 164
melanins - biosynthesis (163) 163
cell proliferation (162) 162
medicine, research & experimental (159) 159
integumentary system (158) 158
autoimmunity (154) 154
dermatology & venereal diseases (153) 153
ultraviolet rays (152) 152
melanins - metabolism (151) 151
rodents (150) 150
metastasis (148) 148
genetics (147) 147
antibodies (145) 145
vitiligo - pathology (144) 144
identification (142) 142
amino acid sequence (140) 140
cytokines (140) 140
cell differentiation (137) 137
stem cells (137) 137
monophenol monooxygenase - metabolism (136) 136
skin neoplasms - metabolism (136) 136
gene-expression (135) 135
kinases (135) 135
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3477) 3477
French (28) 28
German (14) 14
Japanese (12) 12
Russian (7) 7
Chinese (5) 5
Spanish (3) 3
Portuguese (2) 2
Dutch (1) 1
Italian (1) 1
Polish (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


PLoS ONE, ISSN 1932-6203, 04/2012, Volume 7, Issue 4, pp. e35005 - e35005
The expression of melanoma-associated antigens (MAA) being limited to normal melanocytes and melanomas, MAAs are ideal targets for immunotherapy and melanoma... 
PROMISCUOUS GENE-EXPRESSION | CANDIDIASIS-ECTODERMAL DYSTROPHY | AIRE-DEFICIENT MICE | SYNDROME TYPE-I | EPITHELIAL-CELLS | AUTOIMMUNITY | MULTIDISCIPLINARY SCIENCES | ESTABLISHED MELANOMA | PERIPHERAL TISSUE ANTIGENS | T-CELLS | TUMOR-IMMUNITY | Intramolecular Oxidoreductases - immunology | Self Tolerance - immunology | Cancer Vaccines - pharmacology | Humans | gp100 Melanoma Antigen - immunology | CD4-Positive T-Lymphocytes - immunology | Melanoma, Experimental - immunology | Immune Tolerance - immunology | Immunoglobulin G - immunology | Female | Antibodies, Neoplasm - immunology | Melanoma, Experimental - therapy | Mice, Inbred C57BL | Immunologic Factors - immunology | Polyendocrinopathies, Autoimmune - blood | Mice, Knockout | Polyendocrinopathies, Autoimmune - immunology | Thymocytes - immunology | Cancer Vaccines - immunology | Animals | Melanoma - immunology | Autoantigens - immunology | Epithelial Cells - immunology | Cell Line, Tumor | Mice | CD8-Positive T-Lymphocytes - immunology | Melanoma - therapy | Cancer vaccines | Autoimmunity | Antigens | Care and treatment | Immunotherapy | Immunoglobulin G | Melanoma | Skin | T cells | Cancer | Epithelial cells | CD8 antigen | Vaccination | Antibodies | Melanocytes | Lymphocytes T | Vaccines | Thymus | Skin cancer | Vitiligo | Immunology | Lymphocytes | Medical research | Immunoglobulins | Immune response | Dendritic cells | Autoantigens | T cell receptors | Gene expression | Patients | Immunological tolerance | CD4 antigen | Immune systems | Medicine | Thymocytes | Antigen (tumor-associated) | Medical prognosis | AIRE protein | Glycoprotein gp100 | Tyrosinase | Index Medicus
Journal Article
Journal Article
Cell Death and Differentiation, ISSN 1350-9047, 05/2017, Volume 24, Issue 5, pp. 832 - 843
Journal Article
Science Translational Medicine, ISSN 1946-6234, 03/2012, Volume 4, Issue 127, pp. 127ra37 - 127ra37
Although many human cancers such as melanoma express tumor antigens recognized by T cells, host immune responses often fail to control tumor growth for as yet... 
TUMOR-INFILTRATING LYMPHOCYTES | MEDICINE, RESEARCH & EXPERIMENTAL | METASTATIC MELANOMA | PROGNOSTIC-FACTORS | CELL CARCINOMA PATIENTS | B7 FAMILY | CANCER-IMMUNOTHERAPY | MALIGNANT-MELANOMA | PROGRAMMED DEATH-1 LIGAND-1 | T-CELLS | CLINICAL-SIGNIFICANCE | CELL BIOLOGY | Inflammation - pathology | Melanoma - complications | Demography | Follow-Up Studies | Humans | Middle Aged | Gene Expression Regulation, Neoplastic | Laser Capture Microdissection | Male | Young Adult | Inflammation - complications | Melanocytes - immunology | Melanoma - genetics | Melanocytes - pathology | Aged, 80 and over | Adult | Female | Adaptive Immunity - immunology | Child | Tumor Escape - immunology | Skin Neoplasms - pathology | Skin Neoplasms - immunology | Inflammation - immunology | Melanoma - pathology | Reverse Transcriptase Polymerase Chain Reaction | B7-H1 Antigen - genetics | Skin Neoplasms - complications | B7-H1 Antigen - metabolism | Lymphocytes, Tumor-Infiltrating - pathology | Melanoma - immunology | Interferon-gamma - immunology | Skin Neoplasms - genetics | Adolescent | Survival Analysis | Aged | Neoplasm Staging | Lymphocytes, Tumor-Infiltrating - immunology | Translation | Immune response | Cytokines | PD-1 protein | Tumor-infiltrating lymphocytes | Tumor cells | Benign | Melanoma | Melanocytes | Inflammation | Lymphocytes T | Metastases | Antigen (tumor-associated) | PD-L1 protein | gamma -Interferon | Antitumor activity | Cancer | Index Medicus
Journal Article
Science, ISSN 0036-8075, 10/2002, Volume 298, Issue 5594, pp. 850 - 854
Journal Article
PLoS ONE, ISSN 1932-6203, 2011, Volume 6, Issue 4, pp. e18907 - e18907
Journal Article
Cancer Immunology, Immunotherapy, ISSN 0340-7004, 5/2012, Volume 61, Issue 5, pp. 655 - 665
Therapeutic targeting of melanoma antigens frequently focuses on the melanocyte differentiation or cancer-testis families. Antigen-loss variants can often... 
Immunology | ML-IAP | Medicine & Public Health | Melanoma | Cancer Research | Oncology | Immune responses | Livin | TARGET | NY-ESO-1 | SURVIVIN | IMMUNOLOGY | TUMOR-INFILTRATING LYMPHOCYTES | LUNG-CANCER | T-CELL RESPONSES | CANCER-PATIENTS | GENE | ONCOLOGY | ANTIGEN-LOSS VARIANTS | EXPRESSION | Immunity, Humoral - immunology | Inhibitor of Apoptosis Proteins - genetics | Humans | Ipilimumab | Neoplasm Proteins - immunology | CD4-Positive T-Lymphocytes - immunology | Epitopes - immunology | Adaptor Proteins, Signal Transducing - immunology | Neoplasm Proteins - genetics | Antibodies, Monoclonal - immunology | T-Lymphocytes, Cytotoxic - immunology | Inhibitor of Apoptosis Proteins - biosynthesis | HLA-A2 Antigen - immunology | Antigens, Neoplasm - immunology | Neoplasm Proteins - biosynthesis | Antibodies, Monoclonal - pharmacology | Melanoma - pathology | CTLA-4 Antigen - immunology | Apoptosis - immunology | Melanoma - immunology | Adaptor Proteins, Signal Transducing - genetics | Inhibitor of Apoptosis Proteins - immunology | Adaptor Proteins, Signal Transducing - biosynthesis | CD8-Positive T-Lymphocytes - immunology | CTLA-4 Antigen - antagonists & inhibitors | Melanoma - therapy | Immunohistochemistry | Medical colleges | Antigens | Care and treatment | Peptides | HLA histocompatibility antigens | Antibodies | Development and progression | Metastasis | T cells | Viral antibodies | Histocompatibility antigens | Analysis | Enzyme-linked immunosorbent assay | Apoptosis | Antigenic determinants | Tumors | Index Medicus | CD8 antigen | Cytotoxicity | Melanocytes | Lymphocytes T | Immunity | Metastases | CTLA-4 protein | Immunotherapy | Cell survival | Immune response | Cytokines | Therapeutic applications | Tumor cells | Epitopes | Tumor cell lines | Immune response (humoral) | CD4 antigen | Antigen (tumor-associated) | Peptide libraries | Histocompatibility antigen HLA | Differentiation | Original
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 10/2008, Volume 26, Issue 30, pp. 4973 - 4980
Purpose A phase I/II trial was performed to evaluate the safety and immunogenicity of a novel melanoma vaccine comprising six melanoma-associated peptides... 
IMMUNIZATION | PERIPHERAL-BLOOD |